Special Instructions 013 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002
Closed Special Notice Posted
Not the latest version. See the latest special notice from .
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Washington, District of Columbia 20201, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response published Special Instructions 013 announcing the addition of Area of Interest Number 7 to its Easy Broad Agency Announcement solicitation number BAA-20-100-SOL-0002. This Special Notice seeks to support the development of advanced in vitro platforms that integrate human tissue models with immune system components on a single platform.
Under AOI 7, BARDA seeks abstract submissions to develop advanced in vitro platforms integrating 3D microphysiological human tissue models of the lung, liver, gut or heart with immune system components. Interested vendors must request a market research call with BARDA before the deadline of November 1, 2021 to be eligible for consideration. Awards under $750,000 total are expected to support biological modeling of disease, inclusion of multiple immune elements, and accurate reflection of host-pathogen interactions. Submissions must demonstrate continuous monitoring of tissues through built-in sensors for at least four weeks and consider platform materials suitable for automated manufacturing at scale.
Notice text
3 versions
Update #3 · Latest ·
6/30/2021 - Under these Special Instructions 014, BARDA is hereby extending the due date for abstract submissions for "AOI 7: ImmuneChip+" as part of its EZ-BAA. The due date for abstract submissions is now 01 November 2021.
Under these Special Instructions 013, BARDA is now accepting abstract submissions for "AOI #7: ImmuneChip+” as part of its EZ-BAA (BAA-20-100-SOL-0002).
Update #2 ·
6/30/2021 - Under these Special Instructions 014, BARDA is hereby extending the due date for abstract submissions for "AOI 7: ImmuneChip+" as part of its EZ-BAA. The due date for abstract submissions is now 01 November 2021. Please see Special Instructions 013 for a detailed description of the AOI.
Under these Special Instructions 013, BARDA is now accepting abstract submissions for "AOI #7: ImmuneChip+” as part of its EZ-BAA (BAA-20-100-SOL-0002).
Update #1 ·
Under these Special Instructions 013, BARDA is now accepting abstract submissions for "AOI #7: ImmuneChip+” as part of its EZ-BAA (BAA-20-100-SOL-0002).
Files
| File | Type | Posted |
|---|---|---|
| DRIVe EZ-BAA - Special Instructions 013-2.pdf | ||
| DRIVe EZ-BAA - Special Instructions 013.pdf |
Notice history
Show 5 more
15 notices listed here. See the rest on GovTribe.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity